Search

everythinglearnresearchcommunity

for

Search:↓

Extracellular vesicles could offer precise treatments for psychiatric conditions by targeting brain networks.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Research on HIV-1 capsid inhibitors has progressed significantly, with the U.S. leading in contributions.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

The Trichodysplasia spinulosa virus protein can cause abnormal hair growth in mice.

Biomaterials can improve non-viral gene delivery by enhancing DNA uptake and reducing toxicity.

The gelatin/β-TCP scaffold with nanoparticles improves wound healing and skin regeneration.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

The protein's size was reduced, but more work is needed to confirm its function.

Keratinocytes help keep hair follicle cells and skin cells separate in 3D cultures, which is important for hair growth research.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Hair growth can be induced by transplanting certain cells, but these cells lose their properties during culturing. The best cell interaction happens in a liquid medium under gravity, and using collagen doesn't help. Future research could focus on using growth factors to stimulate these cells.

Lipid nanoparticles improve treatment delivery and are key to future therapies, but challenges in manufacturing and safety remain.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

The medication lopinavir-ritonavir may cause severe hair loss.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

A new delivery system makes Curcumin more effective and safer against viruses.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

A rare skin infection in a 10-year-old kidney transplant patient was successfully managed by adjusting medication.

PCR genotyping in cre-loxP mice can be inaccurate due to unintended gene deletions in non-target tissues.

A new patch can deliver stable antibodies over time for potential HIV treatment.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Certain genes controlled by OVOL1 are crucial for creating new hair follicles.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

The nano-carrier makes etoposide safer and more effective against lung cancer.